| Alexis Brae Summerlin, RN | |
|
4200 6th Ave Se Ste 201, Lacey, WA 98503-1042 | |
| (360) 459-8311 | |
| Not Available |
| Full Name | Alexis Brae Summerlin |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 4200 6th Ave Se Ste 201, Lacey, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518723949 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SH0200X | Clinical Nurse Specialist - Home Health | RN9469018 (Florida) | Secondary |
| 364S00000X | Clinical Nurse Specialist | RN9469018 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alexis Brae Summerlin, RN 16888 Royal Poinciana Dr, Weston, FL 33326-1575 Ph: (954) 899-1077 | Alexis Brae Summerlin, RN 4200 6th Ave Se Ste 201, Lacey, WA 98503-1042 Ph: (360) 459-8311 |
News Archive
Geospiza, Inc., the market leading developer of genetic analysis software, today announced the receipt of a Phase I SBIR grant for "Software Systems for Detecting Rare Mutations" from the National Human Genome Research Institute (1R43HG005297-01).
China Kangtai Cactus Biotech Inc., a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that it has signed a three-year marketing and sales agreement with Yongkangmen Health and Drug Chain Store Group Ltd. to sell its nutritious and patented cactus-based products, including nutraceuticals, health food, and health and energy drinks.
The National Institutes of Health has awarded Wake Forest Baptist Medical Center a grant worth an estimated $8 million over five years for the establishment of a new center for research into alcohol addiction.
The specific activity of cyclin-dependent kinase 1 and CDK2 as well as a risk score based on the activity of these enzymes can predict recurrence in patients with renal cell carcinoma, study findings indicate.
Research from the University of Michigan Health System shows the risk for kidney failure among liver transplant recipients is higher following the implementation of Model of End Stage Liver Disease (MELD), a policy change in 2002 that altered how liver transplant allocation is decided.
› Verified 6 days ago